JP2008031074A - Solubilized cosmetic - Google Patents
Solubilized cosmetic Download PDFInfo
- Publication number
- JP2008031074A JP2008031074A JP2006205612A JP2006205612A JP2008031074A JP 2008031074 A JP2008031074 A JP 2008031074A JP 2006205612 A JP2006205612 A JP 2006205612A JP 2006205612 A JP2006205612 A JP 2006205612A JP 2008031074 A JP2008031074 A JP 2008031074A
- Authority
- JP
- Japan
- Prior art keywords
- solubilized
- oil
- phytosterol
- mass
- polyoxypropylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- -1 polyoxypropylene Polymers 0.000 claims abstract description 26
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 15
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 8
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 8
- 229920001451 polypropylene glycol Polymers 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 6
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000600 sorbitol Substances 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 5
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003381 solubilizing effect Effects 0.000 abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000006210 lotion Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 229920002197 Sodium polyaspartate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- HQPBOBUGXWYNEZ-QLMRWRAFSA-N [(2S)-2-[(2R)-3,4-bis(14-methylpentadecanoyloxy)-5-oxo-2H-furan-2-yl]-2-(14-methylpentadecanoyloxy)ethyl] 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCC(C)C)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCC(C)C)=C1OC(=O)CCCCCCCCCCCCC(C)C HQPBOBUGXWYNEZ-QLMRWRAFSA-N 0.000 description 1
- MIJPAVRNWPDMOR-UHFFFAOYSA-N [2-(1,2-dihydroxyethyl)-3-hydroxy-5-oxo-2h-furan-4-yl] dihydrogen phosphate Chemical compound OCC(O)C1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-UHFFFAOYSA-N 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は化粧料に関し、更に詳しくは特定の界面活性剤と多価アルコールを含有する化粧水等の可溶化化粧料に関するものである。 The present invention relates to a cosmetic, and more particularly to a solubilized cosmetic such as a lotion containing a specific surfactant and a polyhydric alcohol.
化粧水等には香料、油分、油溶性薬剤等の非水溶性物質を安定配合するために、可溶化剤が使われている。既存の代表的な可溶化剤としてはポリエチレングリコール硬化ひまし油、ポリオキシエチレンアルキルエーテル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンポリオキシプロピレンアルキルエーテルなどが用いられているが、可溶化能の点で十分満足できるものではなく、エステル構造の物は経時で加水分解の起こる可能性もあった。また、これらの可溶化剤を用いた可溶化化粧料には通常皮膚に潤いをもたせるために多価アルコールが配合されているが、べたつくという問題点があった。 A solubilizer is used in skin lotions and the like in order to stably incorporate water-insoluble substances such as fragrances, oils, and oil-soluble drugs. Typical existing solubilizers include polyethylene glycol hydrogenated castor oil, polyoxyethylene alkyl ether, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene polyoxypropylene alkyl ether, and the like. However, it was not fully satisfactory in terms of solubilizing ability, and the ester structure product could possibly undergo hydrolysis over time. In addition, solubilized cosmetics using these solubilizers are usually mixed with polyhydric alcohol to moisturize the skin, but have a problem of stickiness.
これらの問題点を解決するために可溶化剤として分岐脂肪酸ポリグリコシドを用いる方法(特許文献1参照)やポリグリセリン脂肪酸エステルを用いる方法(特許文献2参照)や水溶性架橋型両親媒性高分子電解質を用いる方法(特許文献3参照)やテルペンアルコールエトキシ化物を用いる方法(特許文献4参照)などが行われている。
本発明は、可溶化能に優れ安定性も良好で、多価アルコールのべたつき感を低減することができる可溶化剤を配合した可溶化化粧料に関する。 The present invention relates to a solubilized cosmetic comprising a solubilizing agent that has excellent solubilizing ability and good stability and can reduce the stickiness of polyhydric alcohol.
本発明者らは係る事情に鑑み鋭意研究の結果、(A)一般式(1)
及び(B)1,3−ブチレングリコール、ジプロピレングリコール、グリセリンおよびソルビトールから選ばれる多価アルコールの1種または2種以上、を配合することにより課題を解決することが出来ることを見出した。
As a result of intensive studies in view of the circumstances, the present inventors have determined that (A) the general formula (1)
And (B) It discovered that a subject could be solved by mix | blending 1 type, or 2 or more types of the polyhydric alcohol chosen from 1, 3- butylene glycol, dipropylene glycol, glycerol, and sorbitol.
香料、油分、油溶性薬剤等の非水溶性物質を含有する化粧料において、上記特定の非イオン界面活性剤と多価アルコールを配合することにより、多価アルコールのべたつき感を低減し、可溶化能に優れ安定性も良好な可溶化化粧料を得ることが出来る。 In cosmetics containing water-insoluble substances such as fragrances, oils, and oil-soluble drugs, the stickiness of polyhydric alcohol is reduced and solubilized by blending the specific nonionic surfactant and polyhydric alcohol. A solubilized cosmetic composition having excellent performance and stability can be obtained.
香料、油分、油溶性薬剤等の非水溶性物質を含有する可溶化化粧料に配合する可溶化剤はフィトステロールにポリオキシプロピレンおよびポリオキシエチレンを付加して合成されるものであり、フィトステロールは大豆油など植物油の脱酸工程で得られるガム質から得ることができる。フィトステロールは単一の化合物ではなく、主にβ−シトステロール、スチグマステロール、カンペステロールなどからなる混合物であり、これらの化合物を単離しても良いが、混合物のまま用いてもかまわない。このフィトステロールに対するポリオキシプロピレンおよびポリオキシエチレンの付加反応は常法によって行うことが出来る。ポリオキシプロピレンの平均付加モル数は5〜30モルであり、ポリオキシエチレンの平均付加モル数は10〜50モルであることが好ましい。 Solubilizers blended with solubilized cosmetics containing water-insoluble substances such as fragrances, oils, and oil-soluble drugs are synthesized by adding polyoxypropylene and polyoxyethylene to phytosterols. It can be obtained from a gum obtained in the deoxidation step of vegetable oil such as bean oil. Phytosterol is not a single compound but a mixture mainly composed of β-sitosterol, stigmasterol, campesterol, and the like. These compounds may be isolated, but may be used as a mixture. This addition reaction of polyoxypropylene and polyoxyethylene to phytosterol can be carried out by a conventional method. The average added mole number of polyoxypropylene is 5 to 30 moles, and the average added mole number of polyoxyethylene is preferably 10 to 50 moles.
本発明の可溶化化粧料にはフィトステロールのポリオキシプロピレンおよびポリオキシエチレン付加物よりなる非イオン界面活性剤を0.01〜20.0質量%、好ましくは0.05〜10.0質量%配合する。 The solubilized cosmetic composition of the present invention contains 0.01 to 20.0% by mass, preferably 0.05 to 10.0% by mass, of a nonionic surfactant comprising phytosterol polyoxypropylene and a polyoxyethylene adduct. To do.
また、本発明の可溶化化粧料には、保湿剤として1,3−ブチレングリコール、ジプロピレングリコール、グリセリンおよびソルビトールから選ばれる多価アルコールの1種または2種以上が配合される。これらの保湿剤は可溶化化粧料全量中に2.0〜30.0質量%、好ましくは5.0〜20.0質量%配合する。 The solubilized cosmetic composition of the present invention contains one or more polyhydric alcohols selected from 1,3-butylene glycol, dipropylene glycol, glycerin and sorbitol as a humectant. These humectants are blended in the total amount of the solubilized cosmetic in an amount of 2.0 to 30.0% by mass, preferably 5.0 to 20.0% by mass.
本発明の可溶化化粧料において、(A)フィトステロールのポリオキシプロピレンおよびポリオキシエチレン付加物よりなる非イオン界面活性剤と、(B)1,3−ブチレングリコール、ジプロピレングリコール、グリセリンおよびソルビトールから選ばれる多価アルコールの1種または2種以上の質量比(A)/(B)は、特に限定されないが、好ましくは、1/100〜1/1、さらに好ましくは、1/50〜1/2である。 In the solubilized cosmetic of the present invention, (A) a nonionic surfactant comprising a polyoxypropylene and polyoxyethylene adduct of phytosterol, and (B) 1,3-butylene glycol, dipropylene glycol, glycerin and sorbitol The mass ratio (A) / (B) of one or more polyhydric alcohols to be selected is not particularly limited, but is preferably 1/100 to 1/1, and more preferably 1/50 to 1 /. 2.
本発明の可溶化化粧料には、化粧品及び医薬部外品などに一般的に配合される、上記成分以外の界面活性剤、油分、保湿剤、増粘剤、水溶性多価アルコール、pH調整剤、キレート剤、薬剤、紫外線吸収剤、紫外線散乱剤、香料、顔料、染料などの他の成分を配合してもよい。それらの成分は、1種ずつ配合してもよいし、2種以上配合してもよい。 In the solubilized cosmetic of the present invention, surfactants other than the above components, oils, humectants, thickeners, water-soluble polyhydric alcohols, pH adjustment, which are generally blended in cosmetics and quasi drugs You may mix | blend other components, such as an agent, a chelating agent, a chemical | medical agent, a ultraviolet absorber, a ultraviolet-ray scattering agent, a fragrance | flavor, a pigment, and dye. Those components may be blended one by one or two or more.
また、本発明の可溶化化粧料には、化粧品及び医薬部外品などにしばしば配合される生理活性物質である各種ビタミンや薬効成分を配合してもよい。そのような生理活性物質としては、例えば、ビタミンC、ビタミンCリン酸エステルマグネシウム、ビタミンCステアリン酸エステル、ビタミンCパルミチン酸エステル、ビタミンCジパルミチン酸エステル、ビタミンCテトライソパルミチン酸エステル、アスコルビン酸グルコース、アルブチン、エラグ酸、トラネキサム酸、油溶性甘草エキス、しゃくやくエキス、トウキエキスなどの美白剤、レチノール、レチノイン酸、ヒアルロン酸、アスタキサンチン、トコトリエノール、ユビキノン、アロエ、オウゴンなどの抗老化剤、グリチルレチン酸、グリチルリチン酸、アミノ酸、糖類、ムコ多糖、加水分解タンパク質、スフィンゴ脂質、セラミド、リン脂質などの肌荒れ防止剤、トコフェロール、酢酸トコフェロール、SOD、β−カロテン、カテキン、ポリフェノールなどの抗酸化剤、γ−オリザノール、ミノキシジル、センブリエキス、トウガラシチンキ、ニコチン酸ベンジル、パントテン酸、ビオチン、エストラジオールなどの育毛剤などが挙げられる。 In addition, the solubilized cosmetic composition of the present invention may be blended with various vitamins and medicinal ingredients which are physiologically active substances often blended in cosmetics and quasi drugs. Examples of such physiologically active substances include vitamin C, vitamin C phosphate ester magnesium, vitamin C stearate ester, vitamin C palmitate ester, vitamin C dipalmitate ester, vitamin C tetraisopalmitate ester, ascorbic acid Whitening agents such as glucose, arbutin, ellagic acid, tranexamic acid, oil-soluble licorice extract, crunchy extract, toki extract, retinol, retinoic acid, hyaluronic acid, astaxanthin, tocotrienol, ubiquinone, aloe, ogon and other anti-aging agents, glycyrrhetic acid , Glycyrrhizic acid, amino acids, saccharides, mucopolysaccharides, hydrolyzed proteins, sphingolipids, ceramides, phospholipids and other rough skin prevention agents, tocopherol, tocopherol acetate, SOD, β-carotate , Catechin, an anti-oxidant such as polyphenols, .gamma.-oryzanol, minoxidil, assembly extract, capsicum tincture, benzyl nicotinate, pantothenic acid, biotin, and the like hair growth agents such as estradiol.
次に、実施例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Next, the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples.
化粧水1
エチルアルコール 5.0質量%
グリセリン 1.0
1,3−ブチレングリコール 5.0
POP(20)POE(25)フィトステリルエーテル
1.0
ヘキサメタリン酸ナトリウム 0.03
トリメチルグリシン 1.0
ポリアスパラギン酸ナトリウム 0.1
ビタミンCテトライソパルミチン酸エステル
0.1
酢酸トコフェロール 0.1
EDTA3ナトリウム 0.1
カルボキシビニルポリマー 0.05
水酸化カリウム 0.02
香料 適量
フェノキシエタノール 適量
精製水 残余
上記処方により常法に従って化粧水1を製造した。油性成分を安定に可溶化できており、透明化粧水が得られた。
Lotion 1
Ethyl alcohol 5.0 mass%
Glycerin 1.0
1,3-butylene glycol 5.0
POP (20) POE (25) Phytosteryl ether
1.0
Sodium hexametaphosphate 0.03
Trimethylglycine 1.0
Sodium polyaspartate 0.1
Vitamin C tetraisopalmitate
0.1
Tocopherol acetate 0.1
EDTA3 sodium 0.1
Carboxyvinyl polymer 0.05
Potassium hydroxide 0.02
Perfume Appropriate amount Phenoxyethanol Appropriate amount Purified water Residue Toner lotion 1 was produced according to the conventional method according to the above formulation. The oily component was stably solubilized, and a transparent lotion was obtained.
化粧水2
グリセリン 6.0質量%
ソルビトール 3.0
1,3−ブチレングリコール 8.0
ヒアルロン酸 0.05
酢酸トコフェロール 0.1
アスコルビン酸グルコース 0.1
トリ2−エチルヘキサン酸グリセリル 0.05
POP(5)POE(30)フィトステリルエーテル
2.0
防腐剤 適量
香料 適量
精製水 残余
上記処方により常法に従って化粧水2を製造した。油性成分を安定に可溶化できており、透明化粧水が得られた。
Lotion 2
Glycerin 6.0% by mass
Sorbitol 3.0
1,3-butylene glycol 8.0
Hyaluronic acid 0.05
Tocopherol acetate 0.1
Ascorbic acid glucose 0.1
Glyceryl tri-2-ethylhexanoate 0.05
POP (5) POE (30) Phytosteryl ether
2.0
Preservative Appropriate amount Perfume Appropriate amount Purified water Residue Toner lotion 2 was produced according to the above formula according to a conventional method. The oily component was stably solubilized, and a transparent lotion was obtained.
化粧水3
1,3−ブチレングリコール 6.0質量%
グリセリン 5.0
ジプロピレングリコール 3.0
エタノール 10.0
オリーブ油 0.2
POP(10)POE(20)フィトステリルエーテル
3.0
グリチルリチン酸ジカリウム 0.1
塩酸アルギニン 0.1
油溶性甘草エキス 0.05
トラネキサム酸 1.0
ユキノシタエキス 0.1
オウゴンエキス 0.1
クエン酸 0.05
クエン酸ナトリウム 0.2
EDTA3ナトリウム 0.05
防腐剤 適量
香料 適量
精製水 残余
上記処方によって常法に従って化粧水3を製造した。油性成分を安定に可溶化できており、透明化粧水が得られた。
Lotion 3
1,3-butylene glycol 6.0% by mass
Glycerin 5.0
Dipropylene glycol 3.0
Ethanol 10.0
Olive oil 0.2
POP (10) POE (20) phytosteryl ether
3.0
Dipotassium glycyrrhizinate 0.1
Arginine hydrochloride 0.1
Oil-soluble licorice extract 0.05
Tranexamic acid 1.0
Yukinoshita extract 0.1
Ogon Extract 0.1
Citric acid 0.05
Sodium citrate 0.2
EDTA3 sodium 0.05
Preservative Appropriate amount Perfume Appropriate amount Purified water Residue Toner lotion 3 was produced according to the above-mentioned prescription according to a conventional method. The oily component was stably solubilized, and a transparent lotion was obtained.
(比較例1)
実施例1のPOP(20)POE(25)フィトステリルエーテルをラウリン酸POE(30)硬化ヒマシ油に変更した以外は実施例1に準じて化粧水を製造した。
(Comparative Example 1)
A lotion was prepared in the same manner as in Example 1 except that the POP (20) POE (25) phytosteryl ether of Example 1 was changed to POE (30) hydrogenated castor oil.
(比較例2)
実施例2のPOP(5)POE(30)フィトステリルエーテルをPOE(20)オクチルドデシルエーテルに変更した以外は実施例2に準じて化粧水を製造した。
(Comparative Example 2)
A lotion was produced in the same manner as in Example 2 except that POP (5) POE (30) phytosteryl ether in Example 2 was changed to POE (20) octyldodecyl ether.
(比較例3)
実施例3のPOP(10)POE(20)フィトステリルエーテルをPOE(20)ソルビタンオレートに変更した以外は実施例3に準じて化粧水を製造した。
(Comparative Example 3)
A lotion was produced in the same manner as in Example 3 except that the POP (10) POE (20) phytosteryl ether in Example 3 was changed to POE (20) sorbitan oleate.
実施例1〜3と比較例1〜3で得られた化粧水について、使用性(べたつき)を美容専門パネル10人の実使用によって判定、評価した結果を表1に示す。
(判定)
◎ : べたつかない
○ : わずかにべたつくが、使用上問題ない範囲である
△ : べたつく
× : 著しくべたつく
(Judgment)
◎: Not sticky ○: Slightly sticky, but in a range where there is no problem in use △: Sticky ×: Significantly sticky
本発明は特定の非イオン界面活性剤と多価アルコールとを配合することにより、可溶化能に優れ安定性も良好で、多価アルコールのべたつき感を低減することができる可溶化剤を配合した可溶化化粧料を提供することができる。 In the present invention, by blending a specific nonionic surfactant and a polyhydric alcohol, a solubilizer that has excellent solubilization ability and good stability and can reduce the stickiness of the polyhydric alcohol is blended. A solubilized cosmetic can be provided.
Claims (2)
(A)一般式(1)
及び(B)1,3−ブチレングリコール、ジプロピレングリコール、グリセリンおよびソルビトールから選ばれる多価アルコールの1種または2種以上、を含有することを特徴とする可溶化化粧料。 In cosmetics containing water-insoluble substances such as fragrances, oils, and oil-soluble drugs,
(A) General formula (1)
And (B) one or more polyhydric alcohols selected from 1,3-butylene glycol, dipropylene glycol, glycerin and sorbitol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006205612A JP4991200B2 (en) | 2006-07-28 | 2006-07-28 | Solubilized cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006205612A JP4991200B2 (en) | 2006-07-28 | 2006-07-28 | Solubilized cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008031074A true JP2008031074A (en) | 2008-02-14 |
JP4991200B2 JP4991200B2 (en) | 2012-08-01 |
Family
ID=39120883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006205612A Active JP4991200B2 (en) | 2006-07-28 | 2006-07-28 | Solubilized cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4991200B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009084588A1 (en) * | 2007-12-27 | 2009-07-09 | Shiseido Company, Ltd. | Water-containing composition which can be used as external composition |
JP2011201820A (en) * | 2010-03-26 | 2011-10-13 | Nippon Menaade Keshohin Kk | Transparent liquid state skin preparation for external use |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5279031A (en) * | 1975-12-26 | 1977-07-02 | Eisai Co Ltd | Cosmetics |
JP2002145722A (en) * | 2000-11-01 | 2002-05-22 | Fancl Corp | Cosmetic |
JP3323339B2 (en) * | 1994-10-25 | 2002-09-09 | 株式会社資生堂 | Cosmetics |
JP2004331522A (en) * | 2003-05-01 | 2004-11-25 | Shiseido Co Ltd | Aerosol type enamel remover |
JP2006111620A (en) * | 2004-09-16 | 2006-04-27 | Kose Corp | Oil-in-water type liquid composition |
-
2006
- 2006-07-28 JP JP2006205612A patent/JP4991200B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5279031A (en) * | 1975-12-26 | 1977-07-02 | Eisai Co Ltd | Cosmetics |
JP3323339B2 (en) * | 1994-10-25 | 2002-09-09 | 株式会社資生堂 | Cosmetics |
JP2002145722A (en) * | 2000-11-01 | 2002-05-22 | Fancl Corp | Cosmetic |
JP2004331522A (en) * | 2003-05-01 | 2004-11-25 | Shiseido Co Ltd | Aerosol type enamel remover |
JP2006111620A (en) * | 2004-09-16 | 2006-04-27 | Kose Corp | Oil-in-water type liquid composition |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009084588A1 (en) * | 2007-12-27 | 2009-07-09 | Shiseido Company, Ltd. | Water-containing composition which can be used as external composition |
JP5545696B2 (en) * | 2007-12-27 | 2014-07-09 | 株式会社 資生堂 | Water-containing composition that can be used as a composition for external use |
JP2011201820A (en) * | 2010-03-26 | 2011-10-13 | Nippon Menaade Keshohin Kk | Transparent liquid state skin preparation for external use |
Also Published As
Publication number | Publication date |
---|---|
JP4991200B2 (en) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998056338A1 (en) | Skin-lightening cosmetic | |
EP0934741B1 (en) | Hair growth stimulants | |
JP2008037764A (en) | Sebum secretion inhibitor and skin external preparation for ameliorating acne | |
JP2010163418A (en) | Cosmetic | |
JP2007238488A (en) | Emulsion type skin care preparation | |
JP2006045126A (en) | Composition for preventing dandruff and itching | |
TWI580438B (en) | Contains a composition of polyunsaturated fatty acids | |
JPH11286423A (en) | Composition for suppressing body odor | |
JP4991200B2 (en) | Solubilized cosmetics | |
JP2015229655A (en) | Skin external preparation | |
JP2010013429A (en) | Scalp preparation for external use | |
JP2007022923A (en) | Hair follicle apoptosis reaction inhibitor and hair cosmetic composition | |
JP2017014120A (en) | Cosmetics | |
JP2006045127A (en) | Composition for preventing dandruff and itching | |
WO2015064681A1 (en) | Composition for external use | |
JP2009091271A (en) | Solubilized cosmetic | |
JP2005132828A (en) | Composition for external application | |
JP2006188461A (en) | Cosmetic | |
JP2013133303A (en) | Advanced glycation end product production inhibitor | |
JP5856761B2 (en) | External preparation for skin and method for producing the same | |
JP3170024B2 (en) | Whitening cosmetics | |
JP2002234828A (en) | Skin whitening cosmetic preparation | |
JP2003238333A (en) | Skin preparation for external use | |
JP2002179549A (en) | Skin care preparation | |
JP5999903B2 (en) | Liquid cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090724 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110524 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110705 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120417 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120507 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4991200 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150511 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |